09 July 2026
09 July 2026
The agency is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.
Sino Biopharmaceutical will receive an upfront payment of $200m from AstraZeneca.
The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.
The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.
Vivani’s NanoPortal technology delivers medication steadily over long periods of time.
The status was granted by the FDA's Office of Orphan Products Development and Office of Pediatric Therapeutics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
